Doximity (DOCS) Cost of Revenue (2020 - 2026)

Doximity (DOCS) has 7 years of Cost of Revenue data on file, last reported at $19.4 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 34.15% year-over-year to $19.4 million in Q1 2026; TTM through Mar 2026 was $70.3 million, a 25.87% increase from a year earlier, with the FY2026 full-year figure at $70.3 million, up 25.87% from the prior year.
• Cost of Revenue for Q1 2026 stood at $19.4 million, up from $18.7 million in the prior quarter.
• Over the last five years, Cost of Revenue for DOCS reached as high as $19.4 million in Q1 2026 and fell as low as $11.8 million in Q1 2022.
• Historically, Cost of Revenue has averaged $14.2 million across 5 years, with a median of $13.6 million in 2024.
• Across the five-year window, Cost of Revenue jumped 63.75% in 2022 and retreated 9.88% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $13.5 million in 2022, then fell by 9.88% to $12.2 million in 2023, then climbed by 16.33% to $14.2 million in 2024, then soared by 31.87% to $18.7 million in 2025, then climbed by 3.78% to $19.4 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $19.4 million in Q1 2026, $18.7 million in Q4 2025, and $16.4 million in Q3 2025.